Another secondary efficacy endpoint was the percentage of patients reaching prespecified goals of LDL cholesterol levels depending on coronary heart disease (CHD) risk factors according to the ATP III guideline. Your Email: What rosuvastatin looks like and contents of the pack.
Moreover, the reduction rate was greater in patients with DM or MetS.
Atherosclerosis. Your Name: (optional) Combo therapy produced an additional significant reduction in the baseline LDL cholesterol of 9.7%.
Epub 2017 Feb 23.Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE–IVUS Investigators.J Am Coll Cardiol. Secondary efficacy endpoints included the percent changes from baseline in other lipids, including total cholesterol, high‐density lipoprotein (HDL) cholesterol, TG, non‐HDL cholesterol, apolipoprotein A1, and apolipoprotein B. In the main study, the efficacy and safety of a combination of rosuvastatin (5, 10, and 20 mg) with ezetimibe (10 mg) were Unable to load your delegates due to an error Therefore, the objective of this study was to compare the LDL cholesterol‐lowering effects of fixed‐dose combinations of ezetimibe 10 mg plus rosuvastatin 5, 10, or 20 mg, as compared with rosuvastatin alone in patients with primary hypercholesterolemia.
2015 Nov 15;116(10):1521-6. doi: 10.1016/j.amjcard.2015.08.010.
European Journal of Gastroenterology & Hepatology:
1. Ezetimibe Rosuvastatin, as calcium 2 QUALITATIVE AND QUANTITATIVE COMPOSITION EZETROL® Each tablet of EZETROL for oral administration contains 10 mg ezetimibe. FAS, full analysis set; E10, ezetimibe 10 mg; R5, rosuvastatin 5 mg; R10, rosuvastatin 10 mg; R20, rosuvastatin 20 mgLDL cholesterol levels at baseline and after treatment. Your account has been temporarily locked due to incorrect sign in attempts and will be automatically unlocked in Rosuvastatin 5 mg film-coated tablets are white to off white, film-coated, round tablets with diameter approx. Diabetes has been listed as a CHD risk equivalent by ATP III.In addition, in our study, the potency of combo therapy was found to be more effective in patients with MetS compared with non‐MetS patients. Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Ono T, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE-IVUS study investigators.J Cardiol. Patients in different groups were treated for a period of 14 days with rosuvastatin 10 mg/d, ezetimibe 10 mg/d, and rosuvastatin 10 mg/d plus ezetimibe 10 mg/d, respectively. Rosuvastatin plus ezetimibe are beneficial for the management of dyslipidemia.We investigated whether rosuvastatin plus ezetimibe improves hepatic steatosis in patients with dyslipidemia.. Methods . COVID-19 is an emerging, rapidly evolving situation.
Elsevier Science